European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

April 23-26, 2022

With the Urinary Pathogen ID/AMR (UPIP)* and Respiratory Pathogen ID/AMR (RPIP)* panels, IDbyDNA is changing the paradigm of infectious disease testing for urinary and respiratory disease and antimicrobial resistance testing.

Learn more about the latest research and innovations in the field of Precision Metagenomics presented at ECCMID 2022.

Abstract Summary For your convenience, download a summary of all our posters presented at ECCMID 2022, featuring a short summary of study methods, findings and conclusions.

View Posters and Poster Presentations

Abstract 02724

Analytical Performance of a Precision Metagenomics Approach for Pathogen Detection in Urinary Tract Infections

M. Mangifesta et al., IDbyDNA, Salt Lake City, UT, USA

The Explify^® Urinary Pathogen ID/AMR Panel* demonstrated high analytical sensitivity for the direct detection of uropathogens representative of several biological classes.

Abstract 03064

Precision Metagenomics for Broad Detection of Genitourinary Pathogens and Associated Antimicrobial Resistance Markers

C. Gonzales et al., IDbyDNA, Salt Lake City, UT, USA

The Explify Urinary Pathogen ID/AMR Panel* demonstrated high percent positive agreement with urine culture, detection of common uropathogens missed by culture, and profiling of AMR markers conferring resistance to widely used antibiotics. Precision Metagenomics provides a powerful addition to the diagnostic toolkit for recurrent or difficult-to-treat UTIs.

Abstract 02327

Uropathogen Detection by Precision Metagenomics in Culture-Positive, Culture-Negative, and Volunteer Urine

R. Stinnett et al., IDbyDNA, Salt Lake City, UT, USA

The Explify Urinary Pathogen ID/AMR Panel demonstrated high positive agreement with urine culture and detection of important uropathogens missed by culture.

Recorded poster presentations and poster downloads coming soon!

Abstract 01663 | Poster 1192

Evaluation of the Respiratory Pathogen ID/AMR Panel Workflow Compared to Standard-of-Care for the Diagnosis of Lower Respiratory Tract Infections

D. Gaston¹, H. Miller¹, J. Fissel², K. Carroll¹, P. Simner¹

1 Johns Hopkins Hospital, Baltimore, MD, USA
2 Children’s Hospital Los Angeles, Los Angeles, CA, USA

The Respiratory Pathogen ID/AMR Panel* should be considered as an adjunct to SoC and would have resulted in an etiologic diagnosis in 6 additional patients.

Abstract 03792 | Poster 1183

Pathogen Surveillance by mNGS for Intubated Patients: A Reflex to Culture Model

P. Kavaliauskas^1,2, N. Couto^3,4, B. Kuklinska⁵, L. Vasovic⁶, S. Vaca⁵, I. Estabrooke⁷, R. Stinnett⁷, J. Rossen^7,8,9, R. Schlaberg⁷, A. Craney^10,11

Culture plus Respiratory Pathogen ID/AMR Panel* provided improved and earlier detection of relevant respiratory pathogens, including cases where disease management would have changed.

1 Weill Cornell Medicine of Cornell University, New York, NY, USA
2 University of Maryland School of Medicine, Baltimore, MD, USA
3 University of Bath, Bath, UK
4 University of Groningen, Groningen, The Netherlands
5 New York Presbyterian Hospital Weill Cornell Campus, New York, NY, USA
6 Weill Cornell Medicine, New York, NY, USA
7 IDbyDNA, Salt Lake City, UT, USA
8 Isala Hospital, Zwolle, The Netherlands
9 University of Utah, Salt Lake City, UT, USA
10 Orlando Health Regional Medical Center, Orlando, FL, USA
11 Previously Weill Cornell Medicine, New York, NY, USA

*For Research Use Only. Not for use in diagnostic procedures.

Recorded symposium presentation coming soon!

Moving Next-Generation Sequencing to Clinical Microbiology Laboratories: The Future is Now!

John W.A. Rossen, PhD, MSc
Next Generation Sequencing (NGS) for Dummies: How to Implement Metagenomics for Respiratory Infections